1-11 of 11
Frederick R. Appelbaum
Close
Sort by
Journal Articles

Soiled soil

Clinical Trials & Observations
Frederick R. Appelbaum
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3847–3848.
https://doi.org/10.1182/bloodadvances.2024013145
Published: 2024
Journal Articles

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis

Clinical Trials & Observations
Sara Zarnegar-Lumley, Todd A. Alonzo, Robert B. Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E. Ries, Jim Wang, Amanda Leonti, Matthew A. Kutny, Fabiana Ostronoff, Jerald P. Radich, Frederick R. Appelbaum, Era L. Pogosova-Agadjanyan, Kristen O’Dwyer, Martin S. Tallman, Mark Litzow, Ehab Atallah, Todd M. Cooper, Richard A. Aplenc, Omar Abdel-Wahab, Alan S. Gamis, Selina Luger, Harry Erba, Ross Levine, E. Anders Kolb, Derek L. Stirewalt, Soheil Meshinchi, Katherine Tarlock
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5941–5953.
https://doi.org/10.1182/bloodadvances.2022008282
Published: 2023
Includes: Supplemental data
Journal Articles

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study

Clinical Trials & Observations
Ibrahim Aldoss, Jun Yin, Anna Wall, Krzysztof Mrózek, Michaela Liedtke, David F. Claxton, Matthew C. Foster, Frederick R. Appelbaum, Harry P. Erba, Mark R. Litzow, Martin S. Tallman, Richard M. Stone, Richard A. Larson, Anjali S. Advani, Wendy Stock, Selina M. Luger
Journal: Blood Advances
Blood Adv (2023) 7 (2): 196–204.
https://doi.org/10.1182/bloodadvances.2022007791
Published: 2023
Includes: Supplemental data
Journal Articles

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Jun Yin, Sawyer Jacobson, Anna Wall, Elisa Quiroz, Anjali S. Advani, Selina M. Luger, Martin S. Tallman, Mark R. Litzow, Matthew C. Foster, Harry P. Erba, Frederick R. Appelbaum, Richard A. Larson, Theresa H.M. Keegan, Wendy Stock
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4085–4092.
https://doi.org/10.1182/bloodadvances.2022007197
Published: 2022
Includes: Supplemental data
Journal Articles

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Anjali S. Advani, Eric Larsen, Kristina Laumann, Selina M. Luger, Michaela Liedtke, Meenakshi Devidas, Zhiguo Chen, Jun Yin, Matthew C. Foster, David Claxton, Kristin Coffan, Martin S. Tallman, Frederick R. Appelbaum, Harry Erba, Richard M. Stone, Stephen P. Hunger, Jennifer L. McNeer, Mignon L. Loh, Elizabeth Raetz, Naomi Winick, William Carroll, Richard A. Larson, Wendy Stock
Journal: Blood Advances
Blood Adv (2021) 5 (2): 504–512.
https://doi.org/10.1182/bloodadvances.2020002439
Published: 2021
Includes: Supplemental data
Journal Articles

Midostaurin in patients with acute myeloid leukemia and FLT3 -TKD mutations: a subanalysis from the RATIFY trial

Clinical Trials & Observations
Maria Teresa Voso, Richard A. Larson, Dan Jones, Guido Marcucci, Thomas Prior, Jürgen Krauter, Michael Heuser, Serena Lavorgna, Josep Nomdedeu, Susan M. Geyer, Alison Walker, Andrew H. Wei, Jorge Sierra, Miguel A. Sanz, Joseph M. Brandwein, Theo M. de Witte, Joop H. Jansen, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Richard F. Schlenk, Arnold Ganser, Sergio Amadori, Yuan Cheng, YinMiao Chen, Celine Pallaud, Ling Du, Alfonso Piciocchi, Gerhard Ehninger, John Byrd, Christian Thiede, Konstanze Döhner, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield, Francesco Lo-Coco
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4945–4954.
https://doi.org/10.1182/bloodadvances.2020002904
Published: 2020
Includes: Supplemental data
Journal Articles

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Clinical Trials & Observations
Filippo Milano, Jonathan A. Gutman, H. Joachim Deeg, Eneida R. Nemecek, Joachim Baumgart, Laurel Thur, Ann Dahlberg, Rachel B. Salit, Corinne Summers, Frederick R. Appelbaum, Colleen Delaney
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3302–3310.
https://doi.org/10.1182/bloodadvances.2020002222
Published: 2020
Includes: Supplemental data
Journal Articles

A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)

Clinical Trials & Observations
Jeffrey E. Lancet, Anna B. Moseley, Steven E. Coutre, Daniel J. DeAngelo, Megan Othus, Martin S. Tallman, Mark R. Litzow, Rami S. Komrokji, Harry P. Erba, Frederick R. Appelbaum
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1683–1689.
https://doi.org/10.1182/bloodadvances.2019001278
Published: 2020
Journal Articles

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Clinical Trials & Observations
Frances Linzee Mabrey, Kelda M. Gardner, Kathleen Shannon Dorcy, Andrea Perdue, Heather A. Smith, Alicyn M. Davis, Cody Hammer, Donelle Rizzuto, Sunny Jones, Kim Quach, Bart L. Scott, Paul C. Hendrie, Mary-Elizabeth M. Percival, Roland B. Walter, Frederick R. Appelbaum, Elihu H. Estey, Pamela S. Becker
Journal: Blood Advances
Blood Adv (2020) 4 (4): 611–616.
https://doi.org/10.1182/bloodadvances.2019000707
Published: 2020
Includes: Supplemental data
Journal Articles

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Clinical Trials & Observations
John C. Byrd, Amy S. Ruppert, Nyla A. Heerema, Alese E. Halvorson, Eva Hoke, Mitchell R. Smith, John E. Godwin, Stephen Couban, Todd A. Fehniger, Michael J. Thirman, Martin S. Tallman, Frederick R. Appelbaum, Richard M. Stone, Sue Robinson, Julie E. Chang, Sumithra J. Mandrekar, Richard A. Larson
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1705–1718.
https://doi.org/10.1182/bloodadvances.2017015396
Published: 2018
Includes: Supplemental data
Journal Articles

US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL

Clinical Trials & Observations
Farhad Ravandi, Megan Othus, Susan M. O'Brien, Stephen J. Forman, Chul S. Ha, Jeffrey Y. C. Wong, Martin S. Tallman, Elisabeth Paietta, Janis Racevskis, Geoffrey L. Uy, Mary Horowitz, Naoko Takebe, Richard Little, Uma Borate, Partow Kebriaei, Laura Kingsbury, Hagop M. Kantarjian, Jerald P. Radich, Harry P. Erba, Frederick R. Appelbaum
Journal: Blood Advances
Blood Adv (2016) 1 (3): 250–259.
https://doi.org/10.1182/bloodadvances.2016001495
Published: 2016
Includes: Supplemental data